Search the Newsreel

Stanley Lifestyles net profit falls 92% in Q1FY27 on shipment delays

Stanley Lifestyles files Q1FY27 unaudited results; net profit falls 92%

Sun Life (SLF) Q2 2026 Earnings Call Transcript

Sun Life Financial (SLF) reported strong Q2 2026 results with double-digit underlying EPS growth and increased earnings across all business segments, including record income in Canada and significant growth in Asia and the U.S. medical stop loss market. The company highlighted advancements in AI, …

Suven Life Sci Consolidated June 2026 Net Sales at Rs 3.57 crore, up 91.02% Y-o-Y

Top Liftoff Mobile (LFTO) Competitors 2026

Birchcliff Energy (TSX:BIR) Stock Faces Profit Squeeze Despite Return To Profit

MetLife’s Q2 Earnings Call: Our Top 5 Analyst Questions

MetLife's Q2 Earnings Call: Our Top 5 Analyst Questions MetLife's second quarter results were marked by broad-based earnings growth, with market participants rewarding the company's performance as shares rose notably after the announcement. Management attributed the positive momentum to strong underwriting across all segments, …

F&G Annuities & Life (FG) Balances Quarterly Loss and Dividends Is Its Earnings Strategy Coherent?

ATAI Beckley earnings beat by $0.03, revenue topped estimates

Stanley Lifestyles consolidated net profit declines 93.94% in the June 2026 quarter

Supriya Lifescience standalone net profit declines 30.90% in the June 2026 quarter

Onelife Capital Advisors reports standalone net profit of Rs 1.76 crore in the June 2026 quarter

Ken Takanashi Sells 3,864 Shares of WAVE Life Sciences (NASDAQ:WVE) Stock

WAVE Life Sciences (NASDAQ:WVE) Director Adrian Rawcliffe Sells 12,700 Shares

WAVE Life Sciences (NASDAQ:WVE) Director Adrian Rawcliffe sold 12,700 shares of the company's stock for approximately $67,183. The sale occurred on August 12th when shares were trading at $5.29. Following the transaction, WVE shares fell to $5.20, near their 12-month low, and the company …

Insider Selling: WAVE Life Sciences (NASDAQ:WVE) Director Sells $42,070.00 in Stock

WAVE Life Sciences (NASDAQ:WVE) Director Heidi Wagner sold 7,000 shares of the company's stock for $42,070, reducing her position by 13.48%. The sale occurred amidst weak trading and quarterly results, with WVE shares near their 52-week low and the company reporting a loss and …

SLF|Sun Life Financial Inc|Price:80.910|Chg%:+0.670

Clifford Modern Living Sets August Board Meeting to Review Interim Results

Suja Life Faces Multiple Investor Investigations

Insider Activity Alert: Banc of California's CRO Parts with 6,000 Shares

Banc of California's Chief Risk Officer, Olivia I. Lindsay, sold 6,000 shares of the company's common stock for $117,000 on August 4, 2026. This transaction leaves Lindsay with 32,842 shares, valued at over $641,000, and is considered a routine move. The article highlights Banc …

Wave Life Sciences (WVE) director’s 3,864-share tax sale under 10b5-1 plan

Ken Takanashi, a director at Wave Life Sciences (WVE), sold 3,864 shares of common stock on August 11, 2026, at a weighted-average price of $6.01 per share. This sale was made under a Rule 10b5-1 trading plan solely to cover tax obligations arising from …

Why California Water Service Group (CWT) Is Back In The Spotlight

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Analyst move puts fresh attention on California Water Service Group Argus recently lowered its target price for California Water Service Group (CWT) to …

FitLife outlines plan to launch at least 4 new Irwin products per quarter beginning in 2027 amid supply chain and Amazon initiatives

Earnings Call Insights: FitLife Brands (FTLF) Q2 2026 MANAGEMENT VIEW * "For the second quarter of 2026, total revenue was $26.5 million, an increase of 65% compared to the same quarter last year" (Chairman & CEO Dayton Judd), and he said the increase was …

Bronstein, Gewirtz & Grossman, LLC Encourages Banc of California, Inc. (BANC) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Banc of California, Inc. (BANC) following a significant stock price drop. The investigation comes after Banc of California reported a net loss of $251.3 million in Q2 2026, falling short of analyst expectations, which …

Transcript : FitLife Brands, Inc., Q2 2026 Earnings Call, Aug 13, 2026

This article is a transcript of FitLife Brands, Inc.'s Q2 2026 Earnings Call held on August 13, 2026. The content provides a summary of the call and is reserved for subscribers, offering detailed financial information and insights into the company's performance for the second …

Is Birchcliff Energy (TSX:BIR) Set To Outperform After Its Recent Rally?

Globe Life Inc. stock outperforms competitors on strong trading day

Globe Life Inc. (GL) shares rose 1.55% to $180.67 on Thursday, breaking a four-day losing streak. The stock's performance outpaced the broader market, with the S&P 500 Index and Dow Jones Industrial Average also seeing gains. This positive trading day occurred amidst an overall …

Top Standard Life (SDLF) Competitors 2026

Maravai LifeSciences (MRVI) group reports 4.0M shares, 2.72% beneficial stake

A group including Hudson View Holdings LLC and JD Squared Holdings II LLC, along with individuals Stuart Feldman, Matthew Barkoff, and Joshua Wool, has reported a collective beneficial ownership of 4,009,250 shares, representing a 2.72% stake in Maravai LifeSciences Holdings, Inc. Class A common …

Paradigm Capital discloses 4.42% Integra LifeSciences (IART) stake with sole voting control

Paradigm Capital Management, Inc. has reported an amended stake in Integra LifeSciences Holdings Corp (IART), disclosing beneficial ownership of 3,439,098 shares, which represents 4.42% of the outstanding common stock. The New York S corporation maintains sole voting and dispositive power over all these shares. …

Renaissance reports 669,418 Lifevantage Corp (LFVN) shares, a 5.31% ownership stake

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported beneficial ownership of 669,418 shares of Lifevantage Corp (LFVN) common stock, representing a 5.31% stake. The filing indicates that Renaissance Technologies LLC holds sole voting and dispositive power over these shares, and certain managed …

A live webcast will accompany LifeVantage's Aug. 27 fiscal-year results

LifeVantage (Nasdaq: LFVN) is set to release its fourth quarter and full fiscal year 2026 financial results on Thursday, August 27, 2026, after market close. The company will host an investor conference call at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on the …

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026

LifeVantage Corporation will release its financial results for the fourth quarter and full fiscal year ended June 30, 2026, after the stock market closes on August 27, 2026. The company will also host a conference call for investors on the same day at 2:30 …

Renaissance Technologies (NYSE: HLF) reports 5.0M-share Herbalife stake at 4.79%

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported a beneficial ownership of 5,024,668 Herbalife Ltd. common shares, which represents 4.79% of the class. This information was disclosed in an Amendment No. 8 to a Schedule 13G filing. The firms maintain sole voting …

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (NASDAQ: OACC) Stock Price, News & Analysis

This article provides an overview of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (NASDAQ: OACC), including its current stock price, fundamental data, and a disclaimer about the information provided. As of the last update, OACC was trading at $10.80, up 0.37%. …

Life360 Director Morin Brit Sells 15,582 Shares for $1 Million

Life360 Director Morin Brit sold 15,582 shares of common stock for approximately $1 million on August 10, 2026, through a pre-established Rule 10b5-1 trading plan. Despite this sale reducing Brit's direct holdings by 52%, the director still maintains a substantial interest in the company …

Anavex Life Sciences Files Proxy, Urges Director Support

Anavex Life Sciences has filed definitive proxy materials for its 2026 Annual Meeting, urging stockholders to support its six director nominees. This move follows a leadership change and a board refresh effort, with the company highlighting progress on its lead CNS candidate, blarcamesine, and …